武漢大眾口腔醫療股份有限公司 Wuhan Dazhong Dental Medical Co., Ltd. (A joint stock company with limited liability incorporated in the People's Republic of China)（於中華人民共和國註冊成立的股份有限公司） Stock Code 股份代號 : 2651 中期報告 2025INTERIM REPORT INTERIM REPORT 2025 中期報告 目錄 | 公司資料 | 2 | | --- | --- | | 財務及業務摘要 | 4 | | 管理層討論與分析 | 5 | | 企業管治與其他信息 | 15 | | 中期簡明綜合損益及全面收益表 | 21 | | 中期簡明綜合財務狀況表 | 22 | | 中期簡明綜合權益變動表 | 24 | | 中期簡明綜合現金流量表 | 26 | | 中期簡明綜合財務資料附註 | 28 | | 釋義 | 38 | 公司資料 董事會 執行董事 姚雪先生 （主席） 沈洪敏女士 郭家平先生 劉紅嬋女士 獨立非執行董事 疏義傑先生 黃素珍女士 王陶沙女士 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 武漢大眾口腔醫療股份有限公司 呈交日期: 2025年9月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02651 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 17,026,140 | RMB | | | 1 RMB | | 17,026,140 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 17,026,140 | RMB | | | 1 RMB | | 17,026,140 | | 2. 股份分類 | 普通股 ...

Core Insights - Despite challenges in the industry due to cost pressures, market competition, and consumer downgrade, Wuhan Dazhong Dental Medical Co., Ltd. reported surprising results in its 2025 semi-annual report, achieving a revenue of 186 million yuan in the first half of 2025 [1] - The company has successfully reduced marginal customer acquisition costs and increased customer lifetime value through a community-focused model, resulting in a 10.9% year-on-year decrease in sales costs to 116 million yuan, a 1.2 percentage point increase in gross margin to 37.8%, and a net profit margin growth to 15.4% [1] - The adjusted net profit, excluding IPO intermediary fees and share-based payment expenses, reached 34.438 million yuan [1] Company Strategy - As a leading player in the Central China region, Dazhong Dental achieved over 40% of new customers from 355,000 patient visits in the first half of the year, reflecting the effectiveness of its "high-frequency, low-price" strategy [1] - The company has built a dental care ecosystem centered around communities, addressing full lifecycle needs and transforming infrequent services into repeat purchase scenarios [1] - The strategic move to list on the Hong Kong stock market in July 2025 injects new momentum into the company's expansion [1] Market Position - Dazhong Dental holds a 2.4% market share in a Central China market projected to reach 25.3 billion yuan by 2029, with a CAGR of 7.8% [1] - The capitalized path enables the company to rapidly replicate its standardized operational system and community service model in other densely populated areas [1] - The "regional deep cultivation + capital empowerment" model creates a competitive advantage during the industry's increasing concentration phase [1] Industry Insights - During the industry's deep adjustment cycle, Dazhong Dental breaks through with multi-dimensional innovation, demonstrating that the dental medical sector still contains structural opportunities [2] - The company relies on a comprehensive cost optimization system, an inclusive service penetration network, and a replicable profit model, reshaping the industry's value curve [2] - This new competitive edge, centered on operational efficiency, service accessibility, and sustainable profitability, becomes a core criterion for capital markets in selecting quality targets [2]

Core Insights - The company reported a revenue decrease of 9.2% year-on-year to RMB 186 million for the six months ending June 30, 2025 [1] - Net profit also saw a decline of 2.2% year-on-year, amounting to RMB 28.6 million [1] - Despite challenging market conditions, the company focused on operational resilience and efficiency through strategic measures, particularly effective cost control [1] Financial Performance - Revenue for the six months ending June 30, 2025, was RMB 186 million, down from the previous year [1] - Net profit for the same period was RMB 28.6 million, reflecting a slight decrease [1] Market Expansion - The company opened 8 new dental clinics during the six months ending June 30, 2025 [1] - The total number of dental chairs increased by 3.6%, from 692 chairs as of June 30, 2024, to 717 chairs as of June 30, 2025 [1] Customer Engagement - The total number of patient visits reached 355,181 during the six months ending June 30, 2025 [1] - New customer visits accounted for 151,998 during the same period [1]

Group 1 - The company reported a revenue of 186 million, representing a year-on-year decrease of 9.2% [1] - Profit attributable to the parent company was 15.88 million, down 22.24% year-on-year [1] - Earnings per share stood at 0.41 [1] Group 2 - The company emphasized operational resilience and efficiency through strategic measures, particularly effective cost control under centralized management to mitigate negative impacts on profitability [1]

Core Viewpoint - The company reported a revenue of 186 million yuan for the six months ending June 30, 2025, representing a year-on-year decrease of 9.2% [1] - The profit attributable to the parent company was 15.88 million yuan, down 22.24% year-on-year, with earnings per share at 0.41 yuan [1] - Despite challenging market conditions in the first half of 2025, the company focused on operational resilience and efficiency through strategic measures, particularly effective cost control to mitigate negative impacts on profitability [1] Financial Performance - Revenue for the period was 186 million yuan, a decline of 9.2% compared to the previous year [1] - Profit attributable to the parent company decreased to 15.88 million yuan, reflecting a year-on-year drop of 22.24% [1] - Earnings per share stood at 0.41 yuan [1] Strategic Focus - The company emphasized operational resilience and efficiency in response to market challenges [1] - Strategic initiatives included effective cost control measures aimed at reducing the negative impact on profitability [1]

武漢大眾口腔醫療股份有限公司 章程 1 | 第一章 | 總則 | 3 | | --- | --- | --- | | 第二章 | 經營宗旨和範圍 | 4 | | 第三章 | 股份 | 5 | | 第一節 | 股份發行 | 5 | | 第二節 | 股份增減和回購 | 7 | | 第三節 | 股份轉讓 | 9 | | 第四章 | 股東和股東會 | 9 | | 第一節 | 股東 | 9 | | 第二節 | 股東會的一般規定 | 16 | | 第三節 | 股東會的召集 | 20 | | 第四節 | 股東會的提案與通知 | 22 | | 第五節 | 股東會的召開 | 24 | | 第六節 | 股東會的表決和決議 | 28 | | 第五章 | 董事會 | 34 | | 第一節 | 董事 | 34 | | 第二節 | 董事會 | 37 | | 第六章 | 總經理及其他高級管理人員 | 43 | | 第七章 | 監事會 | 46 | | 第一節 | 監事 | 46 | | 第二節 | 監事會 | 47 | | 第八章 | 財務會計制度、利潤分配和審計 | 49 | | 第一節 | 財務會計制度 | 49 | | 第二節 | ...

（股份代號：2651） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Wuhan Dazhong Dental Medical Co., Ltd. 武漢大眾口腔醫療股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 修訂公司章程 本公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則第13.51(1)條作 出。 茲提述武漢大眾口腔醫療股份有限公司（「本公司」）日期為2025年6月30日的招股 章程（「招股章程」）以及日期分別為2025年7月8日及2025年8月4日的公告。除另 有界定外，本公告所用詞彙與招股章程所界定者具有相同涵義。 為反映本公司全球發售及超額配股權失效後本公司註冊股本及股本結構的有關變 更，根據本公司於2024年11月22日舉行的2024年第二次臨時股東會作出的授權， 及經董事會批准，本公司已根據全球發售的完成情況，對本公司的公司章程（「公 司章程」）作出相應修訂。 公司章程的修訂詳情如下： | 修訂前條款 | 修訂後 ...

Wuhan Dazhong Dental Medical Co., Ltd. 武漢大眾口腔醫療股份有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不會就本公告全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2651） 截至2025年6月30日止六個月的中期業績公告 武漢大眾口腔醫療股份有限公司（「本公司」）董事會（「董事會」）欣然宣佈本公司 及其附屬公司（統稱「本集團」）截至2025年6月30日止六個月的未經審核綜合財務 業績。本公告包含本集團截至2025年6月30日止六個月的中期報告全文，其內容 是根據香港聯合交易所有限公司（「聯交所」）證券上市規則的相關披露要求編製。 董事會及本公司審核委員會已審閱本集團的未經審核綜合財務業績。本業績公告 於本公司網站( www.chinadzyl.com )及聯交所網站( www.hkexnews.hk )發佈。本公 司將按本公司H股股東選擇收取公司通訊的方式向其寄發截至2025年6月30日止 六個月的中期 ...

Core Viewpoint - The company, Dazhong Oral (02651.HK), announced a board meeting scheduled for August 29, 2025, to consider and approve its interim results for the six months ending June 30, 2025, and to discuss the potential distribution of an interim dividend, if any [1] Group 1 - The board meeting will take place on August 29, 2025 [1] - The meeting will focus on the approval of the company's interim results for the six months ending June 30, 2025 [1] - The company will also consider the distribution of an interim dividend during the meeting [1]